Bausch Health Companies Inc
Bausch Health Companies Inc (BHC) Wheel Strategy
BHC wheel strategy scan found 3 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 22.8%.
Read more
Running a BHC wheel strategy lets you generate consistent premium income on Bausch Health Companies Inc while setting your own entry and exit prices on the underlying. Bausch Health Companies Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own BHC, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best BHC wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on BHC, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable BHC wheel from a losing one.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States.
The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the BHC wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your BHC wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 5.00 | $0.10 | $0.18 | -0.23 | 56 | 79% | 58.1% | 22.8% | 11 |
| Jan 15, 2027 | 5.00 | $0.10 | $0.25 | -0.25 | 112 | 79% | 51.2% | 16.3% | 7,136 |
| Jan 21, 2028 | 3.00 | $0.20 | $0.28 | -0.10 | 483 | 79% | 55.7% | 6.9% | 5,429 |
As of September 25, 2026
Run the Wheel on BHC With Confidence
Find the best BHC wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→